News
Medline is targeting a $55.3B valuation as it returns to public markets in a major 2025 IPO.
Mark is a freelance journalist whose work has been published in The Motley Fool and The Guardian, among other sites. He's worked as a data journalist and has a BA in Economics from the University of Sussex as well as an NCTJ journalism qualification.
